Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that ...

Lebanon: A recent study analyzing data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) has ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Adults with obesity who used medication and received guidance on resistance training and nutrition lost substantially more ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

Eli Lilly said its drugs showed no signs of live injury in the trial. This is welcome news for researchers after Pfizer decided to stop developing its weight loss pill after a trial participant ...

“It's called GLP one receptor,” said Atul Malhotra, MD from the UC San Diego School of Medicine. It’s already FDA-approved to ...